These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31108051)

  • 1. Effects of Tubing Type, Formulation, and Postpumping Agitation on Nanoparticle and Microparticle Formation in Intravenous Immunoglobulin Solutions Processed With a Peristaltic Filling Pump.
    Her C; Carpenter JF
    J Pharm Sci; 2020 Jan; 109(1):739-749. PubMed ID: 31108051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Tubing Type, Operating Parameters, and Surfactants on Particle Formation During Peristaltic Filling Pump Processing of a mAb Formulation.
    Her C; Tanenbaum LM; Bandi S; Randolph TW; Thirumangalathu R; Mallela KMG; Carpenter JF; Elias Y
    J Pharm Sci; 2020 Apr; 109(4):1439-1448. PubMed ID: 31954724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein Nanoparticles Promote Microparticle Formation in Intravenous Immunoglobulin Solutions During Freeze-Thawing and Agitation Stresses.
    Pardeshi NN; Zhou C; Randolph TW; Carpenter JF
    J Pharm Sci; 2018 Jul; 107(7):1852-1857. PubMed ID: 29601840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggregation and Particle Formation of Therapeutic Proteins in Contact With a Novel Fluoropolymer Surface Versus Siliconized Surfaces: Effects of Agitation in Vials and in Prefilled Syringes.
    Teska BM; Brake JM; Tronto GS; Carpenter JF
    J Pharm Sci; 2016 Jul; 105(7):2053-65. PubMed ID: 27233685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Subvisible Particles in Biotherapeutic Prefilled Syringes: The Role of Polysorbate and Protein on the Formation of Silicone Oil and Protein Subvisible Particles After Drop Shock.
    Jiao N; Barnett GV; Christian TR; Narhi LO; Joh NH; Joubert MK; Cao S
    J Pharm Sci; 2020 Jan; 109(1):640-645. PubMed ID: 31689431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced Subvisible Particle Formation in Lyophilized Intravenous Immunoglobulin Formulations Containing Polysorbate 20.
    Zhou C; Qi W; Lewis EN; Randolph TW; Carpenter JF
    J Pharm Sci; 2016 Aug; 105(8):2302-9. PubMed ID: 27290624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Laser Diffraction for Quantification of Protein Aggregates: Comparison With Resonant Mass Measurement, Nanoparticle Tracking Analysis, Flow Imaging, and Light Obscuration.
    Yoneda S; Niederleitner B; Wiggenhorn M; Koga H; Totoki S; Krayukhina E; Friess W; Uchiyama S
    J Pharm Sci; 2019 Jan; 108(1):755-762. PubMed ID: 30237029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Particle shedding from peristaltic pump tubing in biopharmaceutical drug product manufacturing.
    Saller V; Matilainen J; Grauschopf U; Bechtold-Peters K; Mahler HC; Friess W
    J Pharm Sci; 2015 Apr; 104(4):1440-50. PubMed ID: 25605257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What Makes Polysorbate Functional? Impact of Polysorbate 80 Grade and Quality on IgG Stability During Mechanical Stress.
    Grabarek AD; Bozic U; Rousel J; Menzen T; Kranz W; Wuchner K; Jiskoot W; Hawe A
    J Pharm Sci; 2020 Jan; 109(1):871-880. PubMed ID: 31614127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of subvisible particle formation during the filling pump operation of a monoclonal antibody solution.
    Nayak A; Colandene J; Bradford V; Perkins M
    J Pharm Sci; 2011 Oct; 100(10):4198-204. PubMed ID: 21698601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of Stable Nanobubbles on Reconstituting Lyophilized Formulations Containing Trehalose.
    Zhou C; Cleland D; Snell J; Qi W; Randolph TW; Carpenter JF
    J Pharm Sci; 2016 Jul; 105(7):2249-53. PubMed ID: 27287517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of excipients on protein aggregation during agitation: an interfacial shear rheology study.
    Liu L; Qi W; Schwartz DK; Randolph TW; Carpenter JF
    J Pharm Sci; 2013 Aug; 102(8):2460-70. PubMed ID: 23712900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Multicompany Assessment of Submicron Particle Levels by NTA and RMM in a Wide Range of Late-Phase Clinical and Commercial Biotechnology-Derived Protein Products.
    Hubert M; Yang DT; Kwok SC; Rios A; Das TK; Patel A; Wuchner K; Antochshuk V; Junge F; Bou-Assaf GM; Cao S; Saggu M; Montrond L; Afonina N; Kolhe P; Loladze V; Narhi L
    J Pharm Sci; 2020 Jan; 109(1):830-844. PubMed ID: 31647951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of particle shedding from silicone tubing on antibody stability.
    Saller V; Hediger C; Matilainen J; Grauschopf U; Bechtold-Peters K; Mahler HC; Friess W
    J Pharm Pharmacol; 2018 May; 70(5):675-685. PubMed ID: 27367430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collaborative Study for Analysis of Subvisible Particles Using Flow Imaging and Light Obscuration: Experiences in Japanese Biopharmaceutical Consortium.
    Kiyoshi M; Shibata H; Harazono A; Torisu T; Maruno T; Akimaru M; Asano Y; Hirokawa M; Ikemoto K; Itakura Y; Iwura T; Kikitsu A; Kumagai T; Mori N; Murase H; Nishimura H; Oda A; Ogawa T; Ojima T; Okabe S; Saito S; Saitoh S; Suetomo H; Takegami K; Takeuchi M; Yasukawa H; Uchiyama S; Ishii-Watabe A
    J Pharm Sci; 2019 Feb; 108(2):832-841. PubMed ID: 30121316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Filling of High-Concentration Monoclonal Antibody Formulations: Investigating Underlying Mechanisms That Affect Precision of Low-Volume Fill by Peristaltic Pump.
    Shieu W; Lamar D; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2016; 70(2):143-56. PubMed ID: 26797970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Nanoparticle Tracking Analysis for Quantification and Sizing of Submicron Particles of Therapeutic Proteins.
    Zhou C; Krueger AB; Barnard JG; Qi W; Carpenter JF
    J Pharm Sci; 2015 Aug; 104(8):2441-50. PubMed ID: 26017684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of excipients impact on polysorbate 80 degradation in biopharmaceutical formulation buffers.
    Bai L; Zhang Y; Zhang C; Lu Y; Li Z; Huang G; Meng B
    J Pharm Biomed Anal; 2023 Sep; 233():115496. PubMed ID: 37285658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG particle formation during filling pump operation: a case study of heterogeneous nucleation on stainless steel nanoparticles.
    Tyagi AK; Randolph TW; Dong A; Maloney KM; Hitscherich C; Carpenter JF
    J Pharm Sci; 2009 Jan; 98(1):94-104. PubMed ID: 18454482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Afraid of the wall of death? Considerations on monoclonal antibody characteristics that trigger aggregation during peristaltic pumping.
    Deiringer N; Friess W
    Int J Pharm; 2023 Feb; 633():122635. PubMed ID: 36690131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.